Alexander Kamb is senior vice president, Discovery Research. In 2006, Kamb joined Amgen to direct Oncology Research at their South San Francisco site. He took over the leadership of the Neuroscience Therapeutic Area and was promoted to vice president, Research, and was given the remit to build a specialized department within Amgen Research (Genome Analysis Unit) focused on cross-disease-area applications of next-generation sequencing.Prior to joining Amgen, Kamb worked in the biotechnology field specializing in the genetics of cancer, then in the Pharmaceutical sector where he led the Novartis Oncology Research Group.Kamb received his A.B. from Harvard University and his Ph.D. from Caltech after a postdoctoral fellowship at UCSF.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
A2 Biotherapeutics | President and CSO | Jan 1, 2018 | — | Detail |